FDA Orange Book · active-ingredient family
Rimegepant sulfate
Rimegepant sulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:NURTEC ODT · NDA 212728
1
Brand (NDA)
0
Generics (ANDA)
3
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, orally disintegrating
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NURTEC ODTRLD | PFIZER | NDA 212728 | — | Feb 27, 2020 |
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8759372 | Feb 25, 2033 | in 6 yr 9 mo | SubstanceProduct |
| 8314117 | Feb 27, 2034 | in 7 yr 10 mo | SubstanceProductU-2718 |
| 11083724 | Mar 25, 2039 | in 12 yr 11 mo | ProductU-2718 |
Rimegepant sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

